TREVYENT Treprostinil is the only parenteral treatment for PAH that is approved by the FDA for both intravenous (IV) and subcutaneous (SC) administration. The current delivery systems for parenteral treprostinil are multi-component and rather complex.... Read More

By following this link you will be leaving the correvio.com website. Please note that Correvio does not take responsibility for the content displayed on other websites:

ContinueClose